Your institution may have access to this item. Find your institution then sign in to continue.
Title
In brief.
Abstract
The article presents the financial performance of various companies in the U.S. BioCryst Pharmaceuticals Incs. share price has increased up to 17.6 percent following the approval of its flu drug, peramivir, by the U.S. Food and Drug Administration. Pfizer Incs. financial report reveals a decrease in their net income by 3.3 percent in the previous year.